Early-life respiratory syncytial virus infection and asthma

Jessica Tolentino1,2, Madison Coward-Smith1,2, Brian G G Oliver1,2

  • 1School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia.

Insights

Early-life respiratory syncytial virus infections disrupt lung development, increasing risks for asthma and chronic lung diseases. Understanding these impacts is crucial for developing preventative strategies against childhood respiratory illnesses.

Area of Science:

  • Pulmonology
  • Immunology
  • Developmental Biology

Background:

  • Lung development is a prolonged process, extending postnatally, rendering infants vulnerable to respiratory infections.
  • Early-life respiratory syncytial virus (RSV) infection is a significant contributor to severe respiratory diseases in children.
  • Preterm birth and maternal environmental factors exacerbate the risks associated with early-life RSV infections.

Purpose of the Study:

  • To review how early-life RSV infection impacts normal lung development.
  • To explore the mechanisms linking RSV infection to chronic lung diseases like asthma.
  • To highlight the need for improved preclinical models for translational research.

Main Methods:

  • Review of existing literature on early-life respiratory infections and lung development.
  • Analysis of mechanistic studies on RSV pathogenesis.
  • Evaluation of preclinical models for studying lung health outcomes.

Main Results:

  • Early-life RSV infection can disrupt lung structure and function, leading to long-term respiratory issues.
  • Pathogenesis involves a complex interplay of epigenetic regulation, immune activation, and airway remodeling.
  • Current preclinical models offer some insights but highlight the need for better translational approaches.

Conclusions:

  • Early-life RSV infection is a critical determinant of long-term respiratory health.
  • Targeted preventative and therapeutic strategies are needed to mitigate the lasting effects of these infections.
  • Further research using robust translational models is essential to understand and address these challenges.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.